HK inno.N’s GERD drug K-CAB advances to Middle East, North Africa
HK inno.N's GERD drug K-CAB has expanded its momentum to the Middle East and North Africa region. Starting from China and expanding across Asia and North and South America, K-CAB is increasing its global market dominance by advancing to the Middle East …